Bonita Gordon – Neuromuscular & Neurodegenerative Disorders

Available for Pre-Order. Within a few days, this product will be in stock.

 Bonita Gordon – Neuromuscular & Neurodegenerative Disorders

Description:

Management Strategies for:

• Multiple Sclerosis
• Alzheimer’s Disease
• Myasthenia Gravis
• Parkinson’s Disease
• Guillain-Barré Syndrome
• Amyotrophic Lateral Sclerosis

Neuromuscular & Neurodegenerative Disorders remain the nation’s leading cause of disability. These conditions are costly and can be devastating. It is important to diagnose these disorders early and provide effective treatment. Join expert, Bonita Gordon, MSN., RN., APRN-BC, CNRN, and gain new insights into the pathophysiologic changes, clinical manifestations, and diagnostic studies for each of these disorders. The latest information on innovative drugs that can slow down or stop the progression of the disorder is available.

Through engaging presentations and insightful case studies Bonita This will increase your understanding of current issues in practice. The evidence-All healthcare professionals who treat patients with neuromuscular or neurodegenerative disorders will benefit from the use of this content.

Would you like a gift?  Bonita Gordon – Neuromuscular & Neurodegenerative Disorders ?

OUTLINE

Multiple Sclerosis

• There are four types of MS
• Keep an eye out for the Oligoclonal Bands
• ABCs of Medication Management
  • Immunomodulating disease-Modifying agents
  • Corticosteroids
  • Antispasmotic
  • Anticholinergic
  • Antiviral
  • CNS stimulant
  • Antiepileptic
  • Antidepressant
  • Beta blocker
  • Natalizumab
• Take Charge of the Symptoms
  • Optic neuritis
  • Fatigue
  • Ataxia

Alzheimer’s Disease Diagnosis

• Staging the disease
• Disease-Particular Treatment
  • To slow down the progression of cancer, drug therapy
  • Treatment of behavioral manifestations
• Create a therapeutic environment
  • Take part in daily activities
  • Protect yourself from injuries by monitoring and taking precautions
  • Community resources
  • Caregiver stress

Myasthenia Gravis

• Neuromuscular Junction Disorder
  • Autoimmune process
  • Acetyl reduced-Choline receptor sites
• The Edrophonium Test
  • Evaluate the response to edrophonium.
  • Short-Anticholinesterase inhibitor
  • Neurotransmission can be increased
• There are many paths to recovery
  • Medications: anticholinesterase inhibitors. Corticosteroids. Immunosuppressive agents.
  • Thymectomy
  • Plasmapheresis, intravenous immunoglobulin

Parkinson’s Disease

• Substantia Nigra Degeneration
  • Basal ganglia degeneration
  • Dopamine deficiency
• Be aware of the symptoms “T-R-A-P”
  • Tremors at rest
  • Rigidity – cogwheel spinning
  • Akinesia – bradykinesia
  • Posture – Stooped, shuffling gait
• Treatment Options
  • Dopaminergics, Anticholinergics, Dopamine Agonist, MAO Medications-Antiviral medications, COMT inhibitors, B inhibitor
  • Neuroprotective agents
  • Deep brain stimulation

Guillain-Barré Syndrome

• Variants of Syndrome
  • Ascending
  • Pure-motor
  • Descending
  • Miller-Fisher Syndrome
• Treatment Options
  • Plasmapheresis
  • Intravenous immunoglobulin

Amyotrophic Lateral Sclerosis

• Motor Neuron Degeneration
  • Excitotoxic Damage
  • Transport proteins are defective
• Slow, progressive weakness
  • Muscle atrophy
  • Paralysis
  • Respiratory failure
  • Death
• Symptom Management
• Alternatives
  • Megadose vitamin
  • Pancreatic enzymes
  • Wheat germ
  • Snake venom
  • Bee pollen

OBJECTIVES

• Discuss the proper medication management for multiple sclerosis patients.
• Check out the most recent options to treat multiple sclerosis.
• Illustrate how to provide a therapeutic environment for the Alzheimer’s disease patient.
• Explain the latest drug therapy options available to slow down the progression of Alzheimer’s disease.
• Diagramming the recovery pathways for patients with myasthenia Gravis.
• Analyze treatment considerations for the patient with Parkinson’s disease.
• Compare the different syndromes available for patients with Guillain-Barré Syndrome.
• Develop symptomatic management of the patient with amyotrophiclateral sclerosis.